retatrutide clinical trials status trial Retatrutide, an experimental weight-loss drug, has not been approved by the Triple hormone receptor agonist retatrutide
Pay in 4 interest-free payments of $5.35 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
























